The activity of Polrmt is controlled by a few transcription activators (Tfam, Tfb1m, Tfb2m), and gene expression of these activators was similarly suppressed at early and severe DCM stages. This evidence concerns the gene TFB1M and familial dilated cardiomyopathy.